Patent Application
20220265969
The present invention belongs to the fields of microtechnology and devices for research and medical purposes, such as for instance catheters and catheter guides. In particular, the invention features a flow conveyed, steerable device, system and method for e.g. surgical operations.
The Seldinger technique is a well-known method for percutaneous insertion of catheters into a patient's blood vessels. Typically, a large-bore hypodermic needle is used to access the patient's vein or artery. Flashback of venous or arterial blood through the needle indicates to the physician when the tip of the needle is in the lumen of the blood vessel. A catheter guide is then inserted through the needle into the lumen of the blood vessel and the needle is withdrawn. A catheter is then inserted coaxially over the catheter guide into the lumen of the blood vessel. At this time, the catheter guide may be withdrawn, leaving the catheter within the lumen of the blood vessel.
The construction of the catheter guide is critical to the successful completion of the Seldinger technique. The catheter guide must be flexible enough to exit the hypodermic needle and make the sometimes sharp turn into the vessel lumen without damaging or passing through the opposite wall of the vessel. The catheter guide must also be flexible enough to follow any sharp bends or tortuosity in the vessel without damaging the vessel wall. However, such a flexible catheter guide may not be rigid enough to guide a catheter through the tissue and any sharp bends, tortuosity or narrowing in the vessel without pulling back or kinking. This can be extremely problematic in cases where successful catheterization is critical to the survival of the patient.
Standard endovascular catheters or guidewires depend on external mechanical force in order to enter and advance within a blood vessel. The inserted guidewire must therefore be sufficiently rigid in order to withstand the pushing force and avoid buckling, but must also be sufficiently flexible to steer through the tight turns of the vascular system. These conditions impose fundamental limitations in miniaturization and therefore have limits in reachability, i.e. the ability of a catheter or guidewire to advance in an intricate vascular network. To address these limitations, flow-assisted infusion catheters were developed. In these devices, a flexible distal tip is assisted by the blood flow in order to reach tortuous locations (e.g. Magic catheter, Marathon catheter). Despite their flow-assisted distal tip, the catheters must be inserted mechanically and pushed towards the target location.
As an alternative technique, magnetic catheters with magnetic tips were developed. The performances of these catheters are remarkable inside cavities such as heart chambers in terms of stability, controllability and functionality. A variety of 3D magnetic manipulation systems is introduced to apply magnetic fields and magnetic field gradients in a controllable fashion. However, the navigation strategy depends on bending of the catheter, which limits their size (typically above 0.7 mm in diameter) and once again rely on the pushability of the rod.
In order to address and overcome at least some of the above-mentioned drawbacks of the prior art solutions, the present inventors developed a flow directed medical device, which might be embodied as a microcatheter, guidewire, sensor, endoscope and the like, having improved features and capabilities.
The purpose of the present invention is therefore that of providing a flow conveyed device that overcomes or at least reduces the above-summarized drawbacks affecting known solutions according to the prior art.
In particular, a first purpose of the present invention is that of providing a minimally invasive and miniaturized device that does not rely on pushing to be introduced and advanced along a tubular structure such as a blood vessel, but which is to the contrary entirely governed by a fluid flow, such as the blood flow.
A further purpose of the present invention is that of providing a flow directed device having the potential to reach any region in a subject's body at the speed of blood, thus reducing the duration of surgical operations and the related complications.
Still a further purpose of the present invention is that of providing a system and method to deflect and guide an extremely miniaturized and ultraflexible flow directed device such as the one described herein in an efficient and intuitive way, both for in vivo applications and in vitro/on chip applications.
All those aims have been accomplished with the present invention, as described herein and in the appended claims.
In view of the above-summarized drawbacks and/or problems affecting flow directed guidewires and catheters of the prior art, the present invention features a flow directed device according to claim 1.
Another object of the present invention relates to a system configured to release a flow directed device into the bloodstream according to claim 14.
Still another object of the present invention relates to a method for inserting a flow directed device into a subject's bloodstream according to claim 19.
Still another object of the present invention relates to a method for guiding a flow directed device into a subject's body according to claim 21.
Further embodiments of the present invention are defined by the appended claims.
The above and other objects, features and advantages of the herein presented subject matter will become more apparent from a study of the following description with reference to the attached figures showing some preferred aspects of said subject matter.
In the Figures:
Conceptual description of our proposed strategy to navigate the μprobe into the target daughter vessel. Upon reaching a bifurcation, the μprobe tip is laterally moved from the current stream (blue dashed lines) into the target stream (brown dashed lines) with the application of magnetic torque. The pprobe is pulled into the stream with further release of the structure. Black dashed line shows the trajectory of the tip passing through the stagnation streamline (white dashed line) and β denotes the bifurcation angle. b The transveral position of the tip, ytip, is controlled by the magnetic actuation of the head that has length LH, diameter ϕH, and magnetisation m. Upon application of the magnetic field, B, the torque exerted on the head rotates the head and bends the filament leading to an increase in both lift and drag forces. Red dot indicates the tip position. c The equilibrium shape of the pprobe with increasing magnetic field at constant flow velocity (ū=30 cm·s−1). Red dot indicates the tip position. d The equilibrium shape of the μprobe with increasing flow velocity at constant magnetic field (B=8 mT). Red dot indicates the tip position;
The subject matter herein described will be clarified by means of the following description. It is however to be understood that the subject matter described in this specification is not limited to the aspects described herein and depicted in the drawings; to the contrary, the scope of the subject-matter herein described is defined by the claims. Moreover, it is to be understood that the specific conditions or parameters described and/or shown in the following are not limiting of the subject matter herein described, and that the terminology used herein is for the purpose of describing particular aspects by way of example only and is not intended to be limiting.
Unless otherwise defined, technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Further, unless otherwise required by the context, singular terms shall include pluralities and plural terms shall include the singular. The methods and techniques of the present disclosure are generally performed according to conventional methods well known in the art and as described in various general and more specific references that are cited and discussed throughout the present specification unless otherwise indicated. Further, for the sake of clarity, the use of the term “about” is herein intended to encompass a variation of +/−10% of a given value.
The following description will be better understood by means of the following definitions.
As used in the following and in the appended claims, the singular forms “a”, “an” and “the” include plural referents unless the context clearly dictates otherwise. Also, the use of “or” means “and/or” unless stated otherwise. Similarly, “comprise”, “comprises”, “comprising”, “include”, “includes” and “including” are interchangeable and not intended to be limiting. It is to be further understood that where for the description of various embodiments use is made of the term “comprising”, those skilled in the art will understand that in some specific instances, an embodiment can be alternatively described using language “consisting essentially of” or “consisting of.”
In the frame of the present disclosure, the expression “operatively connected” and similar reflects a functional relationship between the several components of the device or a system among them, that is, the term means that the components are correlated in a way to perform a designated function. The “designated function” can change depending on the different components involved in the connection; for instance, the designated function of pumping means operatively connected with a liquid reservoir is that of applying a positive or negative pressure on said reservoir in order to create a liquid flow. A person skilled in the art would easily understand and figure out what are the designated functions of each and every component of the device or the system of the invention, as well as their correlations, on the basis of the present disclosure.
The term “subject” as used herein refers to animals and in particular mammals. For example, mammals contemplated by the present invention include humans, primates, domesticated animals such as cattle, sheep, pigs, horses, laboratory rodents and the like.
As used herein, a “ferromagnetic element” is any material or object that is attracted and/or deflected by the magnetic field produced by a magnet. A “magnet” is any material or object that produces a magnetic field. This definition includes permanent magnets, i.e. an object that creates its own persistent magnetic field, or even electromagnets, a type of magnet in which the magnetic field is produced by an electric current running through closely spaced turns of (usually metallic) wire. Both the magnets and the ferromagnetic materials can be made of elements well-known for their ferromagnetic properties such as iron, nickel, cobalt, rare earth metals such as neodymium or samarium, various kind of alloys or composite thereof such as alnico, ferrite or samarium-cobalt, oxides thereof, naturally-occurring minerals such as lodestone, and many others, as well as any combination of the aforementioned.
As used herein, “treatment”, “treating” and the like generally mean obtaining a desired pharmacological and/or physiological effect. The effect may be prophylactic in terms of preventing or partially preventing a disease, symptom or condition thereof and/or may be therapeutic in terms of a partial or complete cure of a disease, condition, symptom or adverse effect attributed to the disease. The term “treatment” or “treating” as used herein covers any treatment of a disease in a mammal, particularly a human, and includes: (a) inhibiting the disease, i.e., arresting its development; or (b) relieving the disease, i.e., causing regression of the disease and/or its symptoms or conditions such as improvement or remediation of damage. As used herein, the term “prevention” or “preventing” relates to hampering, blocking or avoid a disease from occurring in a subject which may be, for any reason, predisposed to the disease but has not yet been diagnosed as having it for example based on familial history, health status or age.
The term “flexible” is used herein to refer to all or part of the device of the invention that can undergo a deflection, either passively (i.e. without the presence of a deflecting force acting on the device except gravity) or actively (i.e. upon application of a bending force). Generally speaking, the term “deflection” refers to any displacement, expansion, contraction, bending, torsion, twist, linear or area strain, or any other kind of deformation, of at least a portion of the device of the invention. Preferably, a deflection is a bending.
The expression “flexural rigidity” refers to the force couple required to bend a non-rigid structure in one unit of curvature or it can be defined as the resistance offered by a structure while undergoing bending. In a beam or rod, flexural rigidity (defined as El) follows the local deflection equation for beams in curvilinear coordinates, also known as the equation of Euler-Bernoulli:
1/p=M/El
where the curvature is 1/p=dθ/ds. The relationship between bending moment and beam deformation therefore reads as
Which in Cartesian coordinates for large deflections and an initially horizontal beam can be written as
where E is the Young's modulus (in Pa), l is the second moment of area (in m4), y is the transverse displacement of the beam at x, and M(x) is the force couple at x Flexural rigidity has SI units of Pa·m4 (which also equals N·m2).
As used herein, the word “sensing” relates to the ability of a sensor to detect the presence of an item, such as a compound, present in a sample through at least one type of analysis. Additionally, “sensing” might refer to the ability of a sensor to detect a physiological and/or physiopathological activity or parameter, such as an electrical activity, in e.g. a subject's tissue and/or organ.
The word “measuring” relates to the ability of a sensor to estimate one or more of the properties of an item or an environment, such as a compound, present in a sample, such as its concentration or its nature, through at least one type of analysis. Furthermore, in the frame of the present disclosure, the word “monitoring” relates to the ability of a sensor to control and/or record the trend of one or more variable properties of an item or an environment, such as a compound, present in a sample, such as its concentration over time, through at least one type of analysis. Additionally, “measuring” might refer to the ability of a sensor to estimate one or more of the properties of e.g. a subject's tissue and/or organ, such as the ability of a sensor to control and/or record the trend of one or more physiological and/or physiopathological activity or parameter, such as an electrical activity, in a subject tissue and/or organ, even over time.
The expression “conductive track” refers to any film, path, stripe, strand, wire or the like which is electrically conductive in nature. For the sake of clarity, the word “electrode” is herein used to mean the distal part of a conductive track which is in direct contact with e.g. a subject's tissue, fluid or otherwise sample, and might be interchangeable with the word “pad”. However, in embodiments of the invention, the term “electrode” is used to mean both a conductive track and its distal, terminal portion (or pad) configured to interface with e.g. a biological tissue, fluid or otherwise sample. Conductive tracks according to the present disclosure are used to connect and/or close an electrical circuit, and are thus usually electrical connectors or “interconnects”. A conductive track is generally a metallic element that conducts an electric current toward or away from an electric circuit, but can be made of any suitable electrically conductive material, including but not limited to metals such as Au, Pt, Al, Cu, Ir and the like, as well as any alloy, oxides and/or combinations thereof; conductive polymeric materials; composite material such as polymeric materials embedding metal particles and/or metal strands or stripes, including insulating materials functionalized with electrically conductive flakes or fibers, for example carbon-filled polymers; liquid metals, including alloys or oxides thereof, such as gallium or gallium-indium; electrically conductive inks; as well as any suitable combination thereof. Micro-lithography and/or micro-integrated electronics, among other techniques readily available in the art, can be adopted to fabricate the components of the electrodes.
The term “compliant” is intended to include any conformable structure which is compressible, reversibly compressible, elastic, flexible, stretchable or any combination thereof. A “compliant electrode” is any structure or element able to deliver an electric current, and adapted to change its shape according to the shape change of the support it adheres to, without substantially compromising mechanical and/or electrical performances. Examples of compliant electrodes known in the art include metal thin-films (including patterned electrodes, out-of-plane buckled electrodes, and corrugated membranes), metal-polymer nano-composites, carbon powder, carbon grease, conductive rubbers or conductive paints, a review of which is provided in Rosset and Shea (Applied Physics A, February 2013, Volume 110, Issue 2, 281-307), incorporated herein in its entirety by reference. As it will be apparent to those skilled in the art, built-in multilayers or stacks of several layers of any of the above polymeric, composite, metallic and/or oxide materials, as well as combinations thereof, are encompassed in the definition of compliant interconnect.
The expressions “film” or “thin film” relate to the thin form factor of all or part of the device of the invention, such as a support substrate and/or a conductive track. Generally speaking, a “film” or “thin film” as used herein relates to a layer of a material having a thickness much smaller than the other dimensions, e.g. at least one fifth compared to the other dimensions. Typically, a film is a solid layer having an upper surface and a bottom surface, with any suitable shape, and a thickness generally in the order of micrometers or nanometers, depending on the needs and circumstances, e.g. the manufacturing steps used to produce it. In some embodiments, films according to the invention have a thickness comprised between 0.1 μm and 500 μm, such as between 1 μm and 500 μm, between 5 μm and 500 μm, between 10 μm and 500 μm, between 5 μm and 300 μm, between 50 μm and 300 μm between, between 50 μm and 200 μm, between 100 μm and 500 μm, between 200 μm and 500 μm, between 5 μm and 50 μm or between 1 μm and 10 μm. Thin films according to the present disclosure are sized and shaped according to the above-listed thicknesses to comply to the inventive concept behind the invention, namely permitting a fluid flow-driven drag of the device along tubular structures, such as small and tortuous blood vessel networks, without performing any push-pull operation of the device.
A “tubular structure” is any structure having a hollow elongated body. The definition includes simple tubular structures or branched ones, as well as both straight or tortuous tubular configurations. Additionally, a tubular structure might have any shape in terms of contours and/or cross-sections, which may possibly vary along one or more portions thereof, and a cross-sectional size normal to the longitudinal axis spanning from micrometers to centimeters. A tubular structure might include for example microfluidic channels included into microfluidic chips, or bodily tubular structures including, but not limited to, gastrointestinal system structures including oesophagus, urinary system structures including urethra and ureters, blood vessels such as arteries and veins, the lymphatic system, biliary ducts, lacrimal ducts, respiratory system structures including trachea, bronchi and bronchioles, as well as phantom reproduction thereof.
In the frame of the present disclosure, a “soft” material is any material that is either compressible, reversibly compressible, flexible, elastic, stretchable or any combination thereof. The term “stretchable” is herein used to mean an intrinsic or engineered property of a material or structure that allows such material or structure to perform a large elongation upon a strain stress, typically of >5% of the elongation of a soft structure at rest, such as for instance more than about 10%, more than about 20%, more than about 50%, more than about 100% or even more than about 200% of a soft structure at rest, in an elastic behaviour regime and without or with minimal impairment of the mechanical and/or functional performances of the said material or structure along a single or multiple strain stress cycles.
The expression “tensile strength” refers to the measurement of the force required to pull a material or structure to the point where it breaks. The tensile strength of a material is therefore the maximum amount of tensile stress that a material or structure can withstand while being stretched or pulled before failure, for example breaking. There are three typical definitions of tensile strength: 1) yield strength, the stress a material can withstand without permanent deformation, which will cause a permanent deformation of 0.2% of the original dimension; 2) ultimate strength, the maximum stress a material can withstand; and 3) breaking strength, the stress coordinate on the stress-strain curve at the point of rupture.
The present invention features a novel navigation approach that does not require pushing a device, such as guidewires or catheters, to advance inside a tubular structure such as a blood vessel. Thanks to the inventive concept upon which the invention is based, the flow directed device herein described allows to achieve unprecedented results in an extremely efficient fashion. The device can navigate micrometer-sized arteries under the only influence of a fluid flow, e.g. the viscous blood flow, without the guidance of any pushable tool such as a guidewire, and can be externally operated at vessels bifurcations using a magnetic field, such as a spatially uniform magnetic field, by controlling the orientation of the distal magnetic tip. Thanks to the top level expertise of the inventors in the field of micro/nanofabrication, the device of the invention is engineered to be extremely flexible (cross-sectional area ranging from 20 to 15′000 μm2 and Young's modulus ranging from kPa to GPa) in order to conformably comply with a fluid flow and be passively transported by a viscous drag, without being bond to any particular geometry or material. The device can therefore be simply un-winded into (fed to or injected into) the fluid stream at a velocity chosen by the user.
With reference to
A device according to the invention can be fabricated to have several different appearances and shapes such as for instance a solid tubular shape, a flat shape (a thin film), or a hollow tubular or flat shape, to mention some. In one embodiment, at least the distal end 101 and/or the elongated body 102 of the device are configured as a ribbon. The shape and appearance are dependent of the suited function and application, without departing however from the inventive concept of the invention. As a way of example, a hollow device would be preferred in the frame of the present invention for all those applications needing delivery of a fluid to a target region in the body of a subject to be treated, thus rendering de facto the device a catheter or micro-/nanocannula; alternatively, nanodevices or optical fibers can be let flown or slid inside a tubular cavity obtained within the body of the device, thus allowing those tools to reach barely accessible spots in a subject's body through the vascular system. Further, and advantageously, embolization due to the operation of catheters and guidewires is avoided or at least limited with the device of the invention configured as a flat, such as a ribbon-like, film, as the blood would be allowed to flow as usual even in case of a blockage in an artery/vein.
While miniaturization of conventional guidewires or catheters is an open challenge due to the way they are navigated inside the arteries, the inventive concept according to the present invention exploits the small-scale features to mechanically adapt to the blood flow, eliminating the miniaturization issue by taking advantage of it. In other words, the present device can potentially be miniaturized further to be guided in the smallest arteriole.
Accordingly, the device of the invention can be fabricated with diameters (for tubular designs) ranging from about 500 nm to about 500 μm, such as between about 1 μm and about 300 μm, between about 10 μm and about 200 μm or between about 20 μm and about 100 μm such as about 50 μm. For instance, in one embodiment the device of the invention might have a hollow tubular shape with an inner diameter of about 40 μm and outer diameter comprised between about 100 and 200 μm. In some embodiments, the cross section (independent of the design or external surface shape) perpendicular to the longitudinal axis 103 has a dimension comprised between about 500 nm and about 100 μm such as between about 1 μm and about 50 μm, which is a range advantageous for applications envisaging e.g. a deep access into tiny and tortuous vasculature such as the brain vasculature. For the sake of clarity, a “cross section” is a linear dimension that might be selected from the thickness, the diameter, the side or the diagonal, depending on the geometry, of the device of the invention. These dimensions are considered to be the optimal choices in particular for biomedical applications, wherein tiny tubular structures such as brain capillaries are targeted as body tubular structures.
Alternatively, for flat devices, these can be implemented as a thin film element, having a flat appearance and a thickness comprised between about 500 nm and about 30 μm, such as between 1 and 10 μm, between 2 and 20 μm or between 1 and 5 μm, and a width comprised between about 10 μm to about 500 μm, such as between 30 and 300 μm, between 50 and 200 μm or between 50 and 100 μm. The device can come in various length, typically ranging from about 50 cm to about 350 cm or longer. As a way of comparison, typical guidewire for cardiovascular use in e.g. interventional radiology have diameters in the range of 0.014″ to 0.034″ (i.e. from about 350 to about 850 μm or more) and a length in the range of 100 to 400 cm.
In terms of materials, in preferred embodiments one or more of the portions composing the device of the invention (the entire device or at least the distal end 101 and the elongated body 102) have an elastic modulus comprised between about 100 kPa and about 10 GPa, preferably between 500 kPa and 5 GPa such as between about 700 kPa and about 3.5 GPa, thus possibly facilitating, inter alia, the elastic compliance of the device with the pulsatile blood flow. In one embodiment the entire device or at least the distal end 101 and the elongated body 102 are substantially made of a soft polymeric material. Exemplary soft polymeric material can be selected from a non-limiting list comprising thermosets or thermoplastics such as styrene butadiene styrene (SBS) or styrene ethylene butylene styrene (SEBS), Nylon, Polyether block amide (PeBax) polyamide, Polyvinyl alcohol (PVA), polyimide (PI), poly ethylene (PE), poly propylene (PP), polyether etherketone (PEEK), Acrylonitrile butadiene styrene (ABS), epoxys, polytetrafluoroethylene (PTFE); soft foams such as polyurethanes (PU) including reticulated polyurethanes; flexible polyvinyl chloride (PVC), neoprene, uncrosslinked neoprene, cross-linked polyethylene (PE), polyethylene terephthalate (PET) polyether, ethylene-vinyl acetate (EVA), polyethylene-vinyl acetate (PEVA), polypropylene glycol (PPG), latex; elastomeric materials such as silicone rubber (e.g. polydimethylsiloxane PDMS) or fluorosilicone rubber; thermoplastic elastomers such as styrenic block copolymer (SBC), ethylene propylene diene monomer (EDPM) rubber, butyl rubber, nitrile rubber; natural polymeric materials (i.e., non-synthetic polymers, polymers that can be found in nature) and/or polymers derived from the Extra Cellular Matrix (ECM) as spider silk, gelatin, elastin, collagen, agar/agarose, chitosan, fibrin, proteoglycans, a polyamino-acid or its derivatives, preferably polylysin or gelatin methyl cellulose, carbomethyl cellulose, polysaccharides and their derivatives, preferably glycosaminoglycanes such as hyaluronic acid, chondroitinsulfate, dermatansulfate, heparansulfate, heparine, keratansulfate or alginate; anisotropic materials such as liquid crystal elastomers and architected composite hydrogels reinforced with collagen or cellulose fibers, or suitable combinations of any of the foregoing.
Alternatively, the entire device or at least the distal end 101 and the elongated body 102 can be substantially made of composite materials, super-elastic metals or various metals/alloys/oxides such as for instance Kevlar, stainless titanium, steel or stainless steel, nickel titanium alloy (Nitinol), nickel-chromium alloy, nickel-chromium-iron alloy, cobalt alloy, tungsten, cobalt, chrome, nickel, aluminum, copper, molybdenum or any combination thereof. These materials are the ones typically used in the context of medical devices such as guidewires or catheters, being easily sterilisable and manufactured, and biocompatible.
One important aspect addressed by the device of the invention is the distribution of the force along the device: for instance, the viscous drag force of the blood is mechanically propelling the device all along from its access point into the blood stream until its most distal point. This aspect can therefore promote safer passage than standard catheters or guidewires, which require a pushing force from their proximal end that is proportional to the distance travelled by the device, due to the increasing mechanical friction between the catheter/guidewire and the vessel walls. According to the above, therefore, independent of the material used, the flow directed device of the invention has a tensile strength, or ultimate strength, of at least its distal end 101 and/or its elongated body 102 comprised between about 5 and about 200 M Pa, preferably between 50 and 100 M Pa as measured by tensile testing, a range which is considered to be optimal in order to combine a sufficient resistance of the distal portion to drive the entire device along a blood vessel via the blood flow without failure such as breakage. As it will be evident for a person skilled in the art, the tensile strength of the device of the invention, in at least its distal end 101 and its elongated body 102, is the result of a combination of design, materials and dimensions, which can be adapted on a case by case basis depending on the needs and circumstances.
Another key feature of the device according to the invention relates to its flexural rigidity, particularly in at least the distal end 101 and the elongated body 102. Conventional guidewires or catheters mainly depend on external push; thus, the entire device needs to slide on the artery walls in order to be pushed forward. With increasing distance, the force applied on the arteries increase accordingly, which might have serious implications on the inner walls and raise the risk of puncture. In the device of the invention, the fluid flow itself limits the number of contact points with the artery walls, thus drastically reducing the risks of friction and excoriation. Moreover, because the forces are governed by the blood flow, the device cannot exert additional stress on the artery wall than the flow itself, eliminating any risk of puncturing the walls while providing autonomous haptic capabilities. Accordingly, in preferred embodiments of the invention, at least the distal end 101 and the elongated body 102 of the device have a flexural rigidity comprised between about 10−10 and about 10−14 Pa·m−4. As a way of comparison, typical guidewire for cardiovascular use in e.g. interventional radiology having a diameter of around 0.9 mm has usual flexural rigidities of around 10−3 Pa·m4, namely around ten orders of magnitude higher that the device of the invention. Again, the flexural rigidity is the result of a combination of design, materials and dimensions, which can be adapted on a case-by-case basis depending on the needs and circumstances, and which a skilled person would readily figure out and adapt without departing from the inventive concept of the invention.
In some embodiments, depending on the needs, the distal end 101 might be engineered or might comprise a material that will render it floppier (have a lower stiffness and a lower flexural rigidity) than the body 102 of the device, while in other circumstances the distal end 101 and the elongated body 102 may have substantially similar stiffness. The distal end 101 may extend typically from 0.5 to 20 cm, such as 1 to 5 centimeters.
With regards to the proximal end 100, this might have different features in terms of mechanics, material and/or geometry. As will be clarified later on in the present disclosure, the proximal end 100 might comprise additional elements such as fluidic and/or electrical connections, might have a different, typically bigger, shape and/or size and might be composed of one or more materials with e.g. a higher Young's modulus, higher flexural rigidity and/or higher tensile strength in order to e.g. safely and reliably connect with an insertion system. Nonetheless, in some embodiments the proximal end 100 can have the exact or similar features than the distal end 101 and/or the body 102 of the device. The proximal end 100 can compose from about one tenth (1/10) to about one fifth (1/5) of the entire device, and may extend from about 5 to about 80 cm.
In embodiments of the invention, as the one depicted in
Lumen 104 is preferably embodied as a channel, such as a microfluidic channel, having a proximal end inlet 105 and a distal end outlet 106 configured to transport for instance a fluid, rendering de facto the flow directed device of the invention a fluidic/microfluidic device such as a catheter, depending on the needs and circumstances. In some embodiments, the device comprises a plurality, such as an array, of channels or microchannels.
The fluidic channels may be used for instance to supply a compound, such as a pharmaceutical compound, a gas, a buffer medium and the like, to a target body site in order to e.g. pharmacologically stimulating a body tissue. The fluidic channels of the device according to the invention can be used e.g. for delivering drugs such as vasospasm relief drugs or others, to remove locally unfavourable chemical products or waste products, or even to deliver surgical adhesives for fixation purposes. For this, a connection of at least some of the fluidic channels to the outside can be provided via a proximal end inlet 105 of the flow directed device. Additionally or alternatively, the channels can be operatively (fluidically) connected through a proximal end inlet 105 to external devices such as a syringe, a fluidic pump (e.g. mechanical pumps or micropumps, peristaltic pumps and the like) or some other drug delivery device via any suitable connection means. Additionally or alternatively, the channel(s) can be used to transport elements such as nanodevices or optical fibers.
In additional or alternative embodiments according to the invention, the device comprises electrically conductive tracks 400 (
Conductive tracks 400 and/or electrodes 401 can be made of any suitable electrical conductive material, including but not limited to metals such as Au, Pt, Al, Cu, Pt-Ir, Ir, and the like, as well as any alloy thereof, oxide thereof and combinations thereof, composite metal-polymer materials, such as Pt-PDMS composites or Pt-Ir-PDMS composites or Ir-PDMS composites and so forth, as well as conductive polymers such as poly(3,4-ethylenedioxythiophene) polystyrene sulfonate (PEDOT:PSS). In a preferred embodiment, the electrodes are made of non-toxic and biocompatible materials. Conductive tracks 400 and/or electrodes 401 can be placed on or within the substrate composing the flow directed device by any suitable means such as for instance photolithography, electron beam evaporation, thermal evaporation, sputter deposition, chemical vapour deposition (CVD), electro-plating, molecular beam epitaxy (MBE) or any other conventional means known in the art. Conductive tracks 400 might be further at least partially encapsulated to avoid short circuits and failure thereof, i.e. passivated whilst leaving the electrodes 401 exposed through connecting vias.
In a set of embodiments according to the invention, conductive tracks 400 are compliant interconnects. A “compliant interconnect” is any structure or element able to deliver an electric current, and adapted to change its shape according to the shape change of the support it adheres to, without substantially compromising mechanical and/or electrical performances. As it will be apparent to those skilled in the art, built-in multilayers or stacks of several layers of any of the above polymeric, composite, metallic and/or oxide materials, as well as combinations thereof, are encompassed in the definition of compliant interconnect. In some embodiments, stretchable interconnects as the ones described in International Patent Applications WO 2004/095536, WO 2016/110564 and/or WO 2018/100005A1, incorporated herein in their entirety by reference, can be used.
In one set of embodiments, the biomedical device of the invention comprises one or more arrays of elastically stretchable microelectrodes. As used herein, for the sake of clarity and conciseness, a “stretchable microelectrode array” refers to the ensemble of a plurality of interconnects 400 and distal electrodes 401 having the ability to withstand mechanical deformations such as flexing, stretching, torsion or the like, without electrical failure or loss of their electrical features. Stretchable arrays (for instance stretchable gold and/or Cr/Au microelectrode arrays, MEAs) are becoming more and more popular and find convenient applications in various fields. It has in fact been verified that the impedance of microelectrode arrays stay low and stable during the deformation and even after repeated torsions, and therefore facilitate e.g. the recording of small amplitude biological signals and ensure efficient functional electrical stimulation.
The electrical connection between electrodes interconnects 400 and one or more electrical and/or electronic external device 500 can be done in any suitable way. With reference for instance to
While the transportation of the device is passively governed by a fluid flow, the guidance thereof (i.e., steering) is actively performed wirelessly using an external magnetic field able to influence the deflection of the distal end portion 101. In this context, as anticipated, the flow directed device of the invention comprises at least one magnetic area or structure 300, preferably in or on the distal end portion 101, which is configured to be magnetically influenced by an external magnetic field in a way to deflect said distal end portion 101 (
In some embodiments, the device of the invention comprises an element named in the frame of the present disclosure drag member 200. As depicted for instance in
Moreover, depending on the needs and circumstances, the drag member 200 can be configured to be deployable, either passively or actively, wherein for “actively deployable flow directed member” is herein meant that the drag member 200 can be deployed with the use of a mechanical/electrical/electromechanical system, while for “passively deployable flow directed member” is herein meant that the drag member 200 can be deployed by the blood flow itself based on the mechanical features and design of the member. As a way of example, a passively deployable drag member 200 can be configured as parachute-shaped member having several elongated members of a soft material connected between them through a thin film or membrane, opening and closing in turn based on the pumping of blood flood within a vessel. In another exemplary embodiment, an actively deployable drag member 200 can be configured as a balloon or an umbrella-like member capable of popping up from the very distal tip of the device, e.g. from an outlet 106 of a channel 104 running along the device, wherein the channel 104 comprises a mechanical/electrical/electromechanical system, or part thereof, designed to deploy the drag member 200 based on the user's needs. An actuator of said mechanical/electrical/electromechanical system can be located for instance at, or in close proximity of, the proximal end 100 of the device, and operatively connected to the drag member 200. However, said actuator can be physically not in contact with the device, as in the case of a magnetically-actuated electromechanical system.
A drag member 200 can be built-in with the rest of the device or physically connected thereto. In terms of size, the drag member 200 lies in a range comprised between 1 and 500 μm for anyone of the three dimensions (width x length x thickness), in any combination, depending of course on the chosen design. Concerning the materials, a drag member 200 can comprise, or consist of, the same materials already listed elsewhere for the rest of the device, including polymeric, composite, metallic and/or oxide materials, as well as combinations thereof.
Moreover, as exemplarily depicted in
Drag members can be distributed along the elongated body to ensure sufficient drag. Nanoribbos or unilateral denticles that are engineered on the surface of the elongated body can be activated and deactivated on demand depending on the deployment strategy. The activation of these structures increases the total drag force and distribute the drag on the entire length of the device.
Another aspect of the invention relates to a system configured to release a flow directed device according to the invention into a tubular structure, said system comprising:
a) the flow directed device as described herein; and
b) an insertion system 1000 comprising:
i) an insertion member 1100 for accessing a tubular structure;
ii) a releasing unit 1200 operatively connected with the flow directed device, the releasing unit 1200 being configured to gradually release the flow directed device without pushing it. One embodiment of this system is exemplarily depicted in
In the non-limiting embodiment shown in
In a particular embodiment, the releasing unit 1200 comprises or consists of a spool around which the flow directed device is wound. In particular, the flow directed device of the invention is operatively connected with its proximal end 100 to the spool by any suitable mean known in the art such as adhesives, soldering, screwing and the like in a way as to be fixedly coupled to the releasing unit 1200. In embodiments of the invention, moreover, the spool is configured as a removable cartridge. In such a configuration, part or all of the releasing unit 1200 can be easily removed or inserted together with the flow directed device in a single step, thereby facilitating and speeding up operations.
The insertion member 1100 is designed to access a tubular structure, such as for instance a blood vessel. Since the insertion system exploits fluid flow to regulate tension on the structures and transport the device, standard hypodermic needles and cannulas can be used as insertion members 1100 for e.g. percutaneous deployment. The minimal invasive intravascular insertion inside high-pressure arteries such as at the carotid level can therefore avoid open surgery and haemorrhagic complications. The insertion member 1100 can be operatively connected with an elongated member 1110 which might form part of the releasing unit 1200, and which acts as a temporary “container” of the device before the beginning of the releasing operation (see
Additionally, in preferred embodiments, the system of the invention further comprises a liquid reservoir 1400 operatively connected with the insertion member 1100 in a way to introduce a fluid such as a liquid into said insertion member 1100. Actuation of a liquid flow is implemented through the fluidic connection and release of the liquid into the system in order to start the tensioning phase of the device before introduction into a tubular structure.
In some embodiment, the system further comprises pumping means 1300 operatively connected with said liquid reservoir 1400. Said pumping means 1300 might be configured for instance as syringes, mechanical (micro)pumps, peristaltic pumps, haemostatic pumps and the like, or even passive pumping means, exploiting for instance capillary, osmotic or infusion forces. Pumping means 1300 and liquid reservoir 1400 are functional for the introduction and guidance of the device within a subjects' blood vessel, as will be described soon. In a further embodiment, as the one depicted in
In view of the above, one aspect of the invention relates to a method for inserting a flow directed device into a tubular structure, such as a subject's tubular structure, comprising the steps of:
a) providing a system as described herein;
b) introducing the insertion member 1100 into the tubular structure; and
c) operating the releasing unit 1200 in a way as to gradually release the flow directed device into the tubular structure without pushing it. Preferably, the method comprises a step of introducing, such as injecting, a liquid or fluid into the insertion system 1000. In some embodiments, the method is performed for inserting a flow directed device into a subject's bloodstream via a blood vessel.
The insertion is performed by exploiting a fluid flow, such as a user-generated fluid flow, through a hydraulic circuit that regulates pressure at the operation side. For example, with reference to
As a way of example, one non-limiting method of use of the system of the invention involves performing a percutaneous or cutdown procedure to gain access to the vasculature of a subject. The insertion member 1100, which in one aspect is preferably embodied as a hypodermic needle or a cannula, is introduced to reach a blood vessel and kept in place during the entire procedure. Upon introduction of the insertion member 1100 into a subject's body, in a first step a fluid flow of e.g. a physiological solution is gently released from the liquid reservoir 1400 through pumping means 1300, exploiting an active pumping, hydrostatic pressure or capillary action, along the elongated member 1110, which is in turn fluidically connected through its distal outlet to the proximal inlet of the insertion member 1100. The fluid flow is selected based on the needs and circumstances, and is chosen based on the size, tensional strength and/or Young's modulus of the device. Typical fluid flows span in a range comprised between 0.1 and 10 ml/min, such as between 0.3 and 3 ml/min, with velocities typically around 10-30cm/s.
In a second step according to the method, the releasing unit 1200 is actuated in a way as to gradually release the flow directed device throughout the elongated member 1110. In embodiments wherein the releasing unit 1200 comprises or consists of a spool, a stepper motor 1500 can be used to tailor the release and the deployment of the device. Of paramount importance, the fluid stream flowing within the elongated member 1110 keeps the device tensioned along the elongated member 1110 in such a way to avoid buckling of the device. The elongated member 1110 can be designed and configured to be of any size and shape, as long as it guarantees the safe deployment of the device; in some embodiments, the elongated member 1110 can be almost as long as the distal end 101 and the elongated body 102 of the device; in other embodiments, the elongated member 1110 can be shorter than the distal end 101 and the elongated body 102, and can be shaped for instance as a serpentine or a corkscrew to keep the entire system more compact. Moreover, the elongated member 1110 can be configured to be flexible by using a soft material for its manufacture.
In a third step of the method, once the device inserted into a subject's vasculature such as into an artery, the bloodstream drags the device along the artery without any push/pull operation from a physician. If needed, a fluid flow can be constantly kept or provided, from the liquid reservoir 1400 through pumping means 1300 to maintain the tensioning of the device within the subject's artery. Passive pumping means such as an intravenous (IV) bag positioned in order to exploit hydrostatic pressure would be perfectly suitable for the operation. Alternatively, a vascular bypass can be put in place exploiting the blood of a subject as a fluid source, so that the liquid reservoir 1400 becomes the patient itself. The advancement of the device along the vasculature is defined by the operator by actuating the releasing unit 1200. Therefore, contrary to known device such as catheters or guidewires, the device of the invention can be advanced along the chosen path without pushing it, as the pushability of the device is close to zero.
One great advantage of such a mechanism of action is the speed of deployment. In the present method, the device has the potential to reach any region in a subject's body at the speed of blood, thereby reducing the duration of surgical operations and possibly limiting complications.
Moreover, without being bond to any theory, it is believed that the inherent compliance of the device, as well as its completely passive, fluid-regulated mechanism of transportation, can protect the arterial lumen from damages such as escoriations and/or perforations.
Since the device advancement is entirely governed by the flow, the required level of expertise in guiding the catheter is almost null. If combined with advantage of virtually impossible punctures and wall friction, a robotic automatic catheterization can be achieved without imposing safety concerns generally arising from hard and heavy robotic systems. Moreover, the self-adaptation feature of the flow in the presence of obstacles (i.e. fluid follows the path with least resistance) would automatically change the device trajectory around the obstacle. As intuitive analogy, flow will always instantaneously solve an “hydraulic maze”, provided that a flow exists from an inlet to an outlet. The ability to adapt upon geometrical conditions/perturbations while lacking of prior knowledge about the system, equips the device of the invention with some sort of “embodied intelligence”, able to passively self-stabilize in new environmental conditions. Also, there is no need for variable stiffness control as the flow governs over the shape of the device according to the vessel geometry.
Still another object of the invention relates to a method for guiding a flow directed device into a tubular structure, such as ones present in a subject's body, said method comprising:
a) providing a system according to the present invention;
b) providing means 2000 for inducing an external magnetic field 3000 in proximity to said system;
c) inserting a flow directed device into a tubular structure according to the method as previously described; and
d) operating said magnetic field inducer 2000 in a way as to provide an external magnetic field 3000 capable to deflect the distal end 101 of the device in correspondence of a target point of the tubular structure. In some embodiments, the tubular structure is a blood vessel, including branched vessels or networks. For “target point” is herein meant a point or portion of the tubular structure such as turns, branches, bumps (e.g. aneurysms or stenosis) and the like. Means 2000 for inducing an external magnetic field might be for instance at least one or more, such as two, four, six, eight or more electromagnets.
The method for guiding a flow directed device into a subject's body according to the invention exploits both the method for inserting a flow directed device into a tubular structure, such as a blood vessel, and the magnetic characteristics of the device of the invention. Once the device introduced, it can be guided through the application of a uniform or gradient external magnetic field 3000 influencing the off-axis deflection of the distal end 101 by acting on the ferromagnetic area or structure 300.
In a non-limiting embodiment, as exemplarily depicted in
Additionally or alternatively, the magnetic field 3000 can be obtained even via a single coil 2000, and the obtained magnetic field 3000 can be non-spatially uniform (e.g., a gradient magnetic field) in order to pull the device along e.g. blood vessels in case of a small or absent blood flow (e.g. in veins). This configuration enhance the universality of use of the system of the invention in scenarios where a push-pull operation might be needed.
As it will be evident, the devices, systems and methods described in the present disclosure can be used for the treatment, diagnosis, monitoring and/or prevention of a pathological conditions of a subject, preferably a human being, for which the device, system and/or method of the invention might be beneficial.
In a non-limiting example, the devices, systems and methods described in the present disclosure can be used for the treatment, diagnosis, monitoring and/or prevention of a disorder of the Central Nervous System (CNS) in a subject, preferably the brain and its associated structures.
In some embodiments, the devices, systems and methods of the invention can be used to treat or monitor a nervous tissue such as a nerve forming part of the sympathetic nervous system. The devices, systems and methods of the invention can be particularly useful in some conditions in which a sympathicotonic effect (a stimulated condition of the sympathetic nervous system in which there is increased tonus of the sympathetic system) appears, such as a vascular spasm (e.g. cerebral vasospasm) or elevated blood pressure conditions as congenital, chronic or idiopathic hypertension. Accordingly, in one embodiment, the nervous tissue can be electrically modulated, such as stimulated, or monitored by the device of the invention. This effect can be obtained by the introduction of the device into e.g. a segment of the internal carotid artery such as the cervical section (C1), the petrous section (C2), the lacerum section (C3), the cavernous section (C4), the clinoid section (C5), the ophthalmic section (C6) and the communicating section (C7), to modulated e.g. the stellate ganglion, the inferior cervical ganglion, the middle cervical ganglion, the superior cervical ganglion, the carotid body, the cavernous plexus, the ciliary ganglion and the pterygopalatine ganglion. These embodiments are preferred in case the pathological condition to be treated by device, system and methods are e.g. cerebral vasospasm, as Raynaud's disease or Complex Regional Pain syndrome.
In alternative embodiments, treatment-refractive hypertension, i.e. high blood pressure not controlled by medication, can be treated by device by performing electrical ablation inducing renal denervation, wherein nerves in the wall of the renal arteries are ablated by applying electrical pulses to the renal arteries, causing a reduction of sympathetic afferent and efferent activity to the kidney and blood pressure decrease.
The devices, systems and methods of the invention of the invention can even be possibly used for the treatment of other pathological conditions involving an abnormal activation of a portion of the sympathetic nerve trunk, through e.g. ablation of relevant nerves anywhere in either of the two sympathetic trunks. Examples of said pathological conditions are Raynaud's disease, hyperhidrosis, Moyamoya disease, migraines, hyperactive bronchial tubes, long QT syndrome, social phobia or anxiety. Further nervous structures can be treated/ablated such as pudendal nerves, mesenteric ganglia, celiac ganglia, coccygeal ganglia, cervical ganglia, splanchnic nerves, or glossopharyngeal nerves for pain (such as cancer-derived or chronic pain) management, treatment of premature ejaculation and other conditions. In some alternative embodiment, Vagus Nerve stimulation (VNS) can be used for the treatment of intractable epilepsy or treatment-resistant depression, while Vagus Nerve blocking can be used to treat obesity. Furthermore, the device can be used in association with other devices and systems to overcome the secondary effects of certain invasive therapies, such as in case of a catheter-induced coronary artery spasm upon coronary catheterization.
The present invention can also be used for fast and reliable access to deep malformations spots in a subject (e.g. arteriovenous malformations, AVM) or fistulas (e.g. arteriovenous fisulas, AVF). The ability to propell by the fluid stresses facilitates trackability and accessibility in the presence of difficult bifurcations. This aspect is particularly useful in situations where the target vessels are barely captured with fluoroscope images.
Another advantage of flow-directed navigation of ultraflexible micrometer probes is the ability to circumnavigate the arteriovenous system, especially in the presence of major anastomoses. Reaching the target location through arterial vessels and subsequently downstream navigating in the veins, allows tracing the optimal trajectory path for the retrograde advancement of standard venous catheters system. Moreover, the ability to retract the flow-directed probe can be used to mechanically pull the distal portion of a catheter (or guidewire) towards the target region.
The ability to navigate without direct human intervention and with minimal risk of perforation or dissection enables the introduction of teleoperated or autonomous robotic platforms. While standard catheterization techniques require real-time force feedback for safe operation, the device and system of the invention can be safely operated with only visual feedback or with no feedback and trial and error. Forces created by the magnetic field can be maintained below 1 mN, which precludes damage to soft tissue. In addition, the absence of pushing forces nullifies iatrogenic damages induced by the insertion. The practitioner can steer the device using a robotic teleoperation system outside the operation room, eliminating the risk of X-ray exposure to the practitioner. Alternatively, for a given map of the vasculature, the practioner can devise a navigation strategy based on how to release the device and apply the magnetic field, and this plan can be converted to a computer program that can be played during the operation.
Fully automated operation can be realized by a computer program that is equipped with algorithms for planning and navigation. The computer program can use the fluoroscope images to control the release of the device and the magnetic field and guide the device toward a target region. The program can further implement state-of-the-art algorithms based on machine learning and artificial intelligence.
In still other embodiments, the devices, systems and methods of the invention can be used for electrically sensing a physiological parameter or stimulating an electrical response in a nerve of a subject and/or a pharmacological activity. The sensing or stimulation activity can be performed in the frame of a therapeutic or preventive (e.g. for diagnostic purposes) medical treatment in a subject.
Design and Operation of a μProbe-Insertion Device
Unlike conventional endovascular catheters, ultra-flexible and ultra-lightweight filaments cannot simply be pushed into a stream because axial compressive loads will no longer be effectively transmitted due to bending of the μprobe. For this purpose, it was developed a hydromechanical insertion system that seamlessly couples with the vasculature and keeps a flexible μprobe under tension during the entire operation. The proximal extremity of the μprobe was attached to a rigid rod (i.e. plunger) that slid across a sealing gasket at the rear end of a custom-made syringe barrel, and the motion of the rod was controlled by a linear positioner. Gentle pulling of the rod ensured proper loading of the μprobe into the barrel. Saline solution was pumped inside the system through an intake, applying tensile stress to the relaxed filament. Percutaneous cannulation in conjunction with controlled perfusion was performed for the fast and versatile deployment of the μprobe (
Fluid-Structure Interactions in Ultra-Flexible μProbes
The deformation and passive deployment of the μprobe was first studied in a nonuniform viscous flow with curved streamlines. Flexible electronic devices fabricated by depositing conductive elements on thin polymer substrates offer a versatile route for the development of smart μprobes. The inventors manufactured 4 μm thick polyimide ribbons with 200 μm width as generic structures for the study of fluid-body interactions under the influence of flow. Coating the complete surface of the ribbon with a 100 nm thick gold film exaggerates the stiffness of functional μprobes with patterned electrical circuits.
Cylindrical magnetic heads with varying sizes (diameter on the order of 200 μm) were fabricated from a hard-magnetic elastomer composite using a moulding process. The experiments were performed inside biomimetic vascular networks made from photopolymer or elastomer using 3D printing and sacrificial moulding, respectively. A Newtonian fluid matching the viscosity of blood was pumped into the channels. The inventors regulated the average fluid velocity, ū, according to the size of the vessels to stay in the physiologically relevant regime.
A tortuous fluidic scenario was realized to replicate challenging vascular trajectories as shown in
The sustained tension on the μprobe provided by the viscous stresses differentiate the proposed deployment system from conventional strategies. Standard push-based endovascular devices rely on the outward wall contact to be able to transmit the axial force along the structure in non-linear trajectories (
Adaptive Transport of μProbes in Complex Vessel Phantoms
Using elastohydrodynamic coupling for propulsion enables enticing opportunities for μprobes navigating inside highly curved, structured, or dynamically changing environments. It was explored whether the elastic body could continuously morph in accordance with the geometry of the channels by testing the devices in a phantom with a braided channel forming a 3D knot with curvature as high as 0.25 mm-1 (
The rapid pursuit of streamlines without any external manipulation set the ground to test whether the μprobes can pass through occlusions mimicking extreme vascular stenoses. Inventors fabricated a channel with two internal occluding walls where the only passage was provided through a circular window with a diameter twice as large as the size of the magnetic head. Computational Fluid Dynamics (CFD) simulations visualized the 3D streamlines inside the channel and quantified the distribution of flow velocity (
Magnetic Actuation of the Tip for Controlled Bending of the μProbe
While the translational motion of the μprobe is controlled by the drag forces, selection of a specific path requires the application of external torque. It was observed that the transversal tip position of the μprobe, ytip, right before entering a bifurcation is a reliable indicator for the direction the μprobe is going to take (
It was systematically studied the effects of the magneto-elasto-hydrodynamic coupling on ytip to develop a robust strategy for navigating pprobes. Inventors fabricated a representative μprobe with a cylindrical magnetic head (ϕH=350 μm and LH=1 mm) and used this prototype for the following characterization experiments, unless stated otherwise. Upon application of the magnetic field, the head rotated in order to align with the direction of the field, which changes the distribution of hydrodynamic forces and elastic stresses, leading to a new equilibrium configuration (
At higher B, magnetic head rotated further, which resulted in the entry of the pprobe tip into the bottom half of the channel. The effect of magnetic actuation was incorporated into a computational model by discretizing the flexible head and applying magnetic moment at the corresponding nodes. It was tuned the magnetization value to match the equilibrium shape at a certain B and u, and used the same calibrated value for the following simulations.
Next, the inventors performed a velocity sweep at B=8 mT. With increasing u, the contribution of the hydrodynamic forces to the final shape also increases, resulting in a straightening of the μprobe. As a result, the tip eventually moved from the bottom to the upper half of the channel (
Controlled Navigation of μProbes in Fluidic Networks
After establishing a method for effective tip positioning under flow, the inventors tested the success of steering in the presence of bifurcations. The pprobe was fed into a channel that splits into two symmetrical daughter vessels with β=40° and ū=30 cm·s-1. Two distinct navigation strategies for selecting daughter vessels were found. In Controlled-Lift (CL), the rotation of the head drifts the structure towards the selected streamline by hydrodynamic lift (
After recording the results of several navigation trials at different magnetic fields, it was possible to discriminate two separate regimes favouring navigation based on CL and CH.
Although the inventors showed navigation in a single plane, magnetic steering can easily be extended to 3D trajectories. The inventors used the 3D design of the phantom to coordinate the application of the magnetic field with the release of the μprobe during navigation. Real-time closed-loop feedback control in the absence of a map requires 3D imaging of the vessels and the probe head. In principle, controlled application of magnetic torque only when the μprobe approaches bifurcations would suffice for reaching target locations. Magnetic continuum devices provide a rich repertoire of actuation modes that can generate propulsion also inside stationary fluids: by actuating the head with time-varying magnetic fields, entry into hydrodynamically unfavourable vessels can be facilitated. With further miniaturization, navigation inside microfluidic channels as small as 100 μm in width became feasible. μprobes with a size of 25 μm×4 μm and a 40-μm diameter magnetic head was successfully transported in less than two seconds. Using μprobes within a similar size range, distal microvasculatures in the body may be reached, a feature that is currently impossible to achieve up to the inventors' knowledge.
Finally, the implemented navigation strategy is compatible with the deployment of multiple μprobes. The inventors iteratively steered four pprobes to pre-determined target locations in a phantom with three bifurcations. The profile of the flow around the existing μprobes autonomously creates alternative paths for the incoming μprobes. Thus, the number of μprobes that can be simultaneously deployed is only limited by the relative size of the probe with respect to the vessel diameter.
Local Characterization of Flow Using Electronic μProbes
After establishing the navigation strategy, it was explored the possibility to dynamically record physiological parameters such as electric potential, temperature, or flow characteristics using μprobes. Polyimide substrate was used to fabricate the main chassis while gold and platinum strips were deposited to form electrodes and electrical circuits, respectively. As a proof of concept, a μprobe that uses convective heat transfer was engineered to measure the characteristics of local fluid flow. Upon injection of current into the heater circuit, the generated heat is transferred to the sensor circuit at a rate determined by the velocity profile of the fluid. The fabricated electronic pprobes consisted of a 0.1 mm×2 mm heating element and a 200 μm×500 μm sensor component, positioned 50 μm apart from each other (
Conventional flow sensors that are based on heat transfer operate either in continuous mode or pulsed mode. In continuous mode, the change in the sensor resistance with the flow is monitored. As a result, this measurement requires high Signal-to-Noise Ratio (SNR), making it challenging to be implemented on miniaturized devices. The flow sensors of the invention were operated in pulsed mode, by measuring the Time-Of-Flight (TOF) between the injection of current to the heater and the detection of peak resistance at the sensor. This method requires high sampling rate, which does not pose a trade-off with miniaturization.
The input to the heater was a 10-ms current pulse with 4 mA peak value and the sensor resistance was recorded at 5 kHz sampling rate (FIG. 22b). A single temporal readout was acquired within 150 ms under physiologically relevant fluidic regimes. The speed of sensing allowed real-time interrogation of the flow during navigation. The inventors performed a series of measurements at the wall of a channel with 2×2 mm2 cross-sectional area at varying fluid velocities. The data showed an exponential decrease in the TOF with increasing u (
To validate the calibration curve at different channel geometries and flow conditions, the inventors made on the fly measurements of τwall while being navigated within structured channels. The μprobe was deployed into a stenotic region where the cross-sectional area of the channel was reduced from 2×2 mm2 to 1×1 mm2 (
Ex Vivo Demonstration Using Microscale μProbes and μCatheters
To test the feasibility of the navigation of the μprobes under physiological conditions, the inventors performed ex-vivo tests on perfused rabbit ears (
Slender filaments in different forms and material composition may further extend the capabilities of the proposed concept of flow-driven navigation. Conventional catheters are manufactured as tubes that enable injection of contrast agents, stents and embolization agents, such as glues or microwires, or even allow collection of blood clots. Motivated by these capabilities, the inventors fabricated elastomer microtubes using a thermal polymerization technique. A tubular magnetic head was glued to the distal end of the flexible tube to complete the μcatheter. This protocol allows fabricating Polydimethylsiloxane (PDMS) pcatheters with outer diameter as small as 120 μm and several cm-long (
Assuming equal flow distribution at the first two bifurcations and no other prior bifurcation, the inventors estimated the diameter of the artery at the point D to be 300 μm. Experimental observation corroborated with this estimation; the μprobe in
Experimental Platform.
The experimental setup consists of an electromagnetic manipulation system, a linear positioner, and a fluid circuit (
Fabrication of Electronic μProbes.
Device were fabricated using standard microfabrication techniques. Briefly, generic μprobes have been prepared by spin-coating on a 4-inch Si wafer a 4 μm-thick layer of polyimide (P12610 Hitachi Chemical DuPont MicroSystems GmbH). A positive photoresist (AZ1512, 2 μm exposed by Heidelberg Instruments MLA150, 405 nm and 104 mJ·cm-2 and developed by AZ 726 MIF developer for 45s) has been used as mask for sputtering (Alliance Concept AC450) a 100 nm-thick layer of gold in stripes of 250 μm width and 9 cm length, followed by lift-off in acetone. The μprobe borders have been then laser cut (Optec MM200-USP) and detachment from the wafer has been done manually. The fabrication of the flow sensors involves the sputtering of titanium and platinum layers serving for adhesion and electrical conduction, respectively. To add the two serpentines, designated as temperature sensor and heater, another 25 nm-thick layer of platinum has been sputtered over the wafer, after surface activation by argon plasma (Alliance Concept AC450). The shapes of the traces and serpentines were defined using spin-coating and removal of positive photoresists (AZ9260, 8 pm and AZ1512, 2 μm). The electrical circuits were sandwiched between polyimide layers.
The magnetic head for all μprobes was fabricated from a composite of
PDMS and Neodymium Boron Iron (NdFeB) microparticles with an average diameter of 5 μm (Magnequench, Germany), mixed at a mass fraction of 1:1. The structures were cured at 65° C. in the oven in a custom-made mould. The size of the cylindrical magnetic heads varied from 40 μm to 350 μm in diameter and from 500 μm to 3 mm in length. Magnetization was performed using an impulse magnetizer (Magnet-Physik) at a field strength of 3′500 kA-m-1. The magnetic head was attached to the distal end of the Kapton ribbon using epoxy and manual positioners (Thorlabs). The electrical measurements were performed using a sensitive dual-channel source measure unit (Keysight B2902A).
Fabrication of μCatheters.
A 40 μm-diameter tungsten wire (Goodfellow) was immersed in PDMS (10:1 ratio) and heated with electrical current at a density of 320 A-mm-2. Thermal dissipation provided by Joule's heating ensured local polymerization around the wire. The thickness of the PDMS pcatheter was determined by the time of polymerization. The wire coated with the polymerized PDMS was then immersed in an acetone bath and vigorously agitated to remove uncured PDMS. After completing curing in an oven at 65° C. for 2h, the tungsten wire was first gently and mechanically disengaged from the PDMS coat using tweezers. Next, to apply a distributed load, the PDMS μcatheter was sandwiched between two sheets of PDMS and the tungsten wire was gently pulled out while applying pressure on the PDMS sheets. A tubular magnetic head was bonded to the distal end of the μcatheter using PDMS as a glue and a tungsten wire to prevent clogging.
Ex Vivo Experiments.
Navigation experiments were performed with ex vivo Rex rabbit (weight between 2.8 kg and 3.5 kg) ears immediately following their delivery from a local butcher. The ears were perfused with Phosphate-Buffered Saline (PBS) solution 1× (Sigma Aldrich) in the central artery shortly after excision. The μprobes were introduced into the central ear artery using the insertion device and a 21 G hypodermic needle. A 3.10-3 w/v % of Pluronic-F127 solution (Sigma Aldrich) was added to the PBS solution to avoid adhesion of the PDMS tubes to the barrel of the insertion system. Mean perfusion flow was maintained at a rate of 90 μL-s−1.
While the invention has been disclosed with reference to certain preferred embodiments, numerous modifications, alterations, and changes to the described embodiments, and equivalents thereof, are possible without departing from the sphere and scope of the invention. Accordingly, it is intended that the invention is not limited to the described embodiments, and be given the broadest reasonable interpretation in accordance with the language of the appended claims.
| Number | Date | Country | Kind |
|---|---|---|---|
| 19186379.4 | Jul 2019 | EP | regional |
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/IB2020/056374 | 7/7/2020 | WO |
